Interstitial Lung Disease News and Research

RSS
Interstitial lung disease (ILD) is a broad group of lung diseases comprising of more than a hundred distinct disorders. All of these involve scarring or inflammation of the interstitial lung tissue and affect the volume of oxygen that can reach the bloodstream via the respiratory system.
UAB study suggests potential treatment target for IPF

UAB study suggests potential treatment target for IPF

Nintedanib drug can benefit patients with broad range of scarring lung diseases

Nintedanib drug can benefit patients with broad range of scarring lung diseases

FDA approves first drug to treat patients with rare lung condition

FDA approves first drug to treat patients with rare lung condition

Association found between gene variant and lung disease in the form of systemic vasculitis

Association found between gene variant and lung disease in the form of systemic vasculitis

Researchers find cause, treatment for CVID lung disease using precision medicine

Researchers find cause, treatment for CVID lung disease using precision medicine

A holistic approach key to minimize treatment complexity in patients with interstitial lung disease

A holistic approach key to minimize treatment complexity in patients with interstitial lung disease

New clinical practice guideline on home oxygen therapy for children

New clinical practice guideline on home oxygen therapy for children

Researchers identify link between mucus in the small airways and pulmonary fibrosis

Researchers identify link between mucus in the small airways and pulmonary fibrosis

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Toxic effects of drugs in the lungs 'more widespread than thought'

Toxic effects of drugs in the lungs 'more widespread than thought'

Researchers identify common genetic connection in lung conditions

Researchers identify common genetic connection in lung conditions

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Veracyte to present data demonstrating potential of Envisia Genomic Classifier to improve ILD diagnosis

Veracyte to present data demonstrating potential of Envisia Genomic Classifier to improve ILD diagnosis

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

New guideline developed to help physicians diagnose idiopathic pulmonary fibrosis

New guideline developed to help physicians diagnose idiopathic pulmonary fibrosis

Patients and families gather to gain more awareness, knowledge about myositis

Patients and families gather to gain more awareness, knowledge about myositis

New safety guideline released for prescribing biological therapies in inflammatory arthritis

New safety guideline released for prescribing biological therapies in inflammatory arthritis